Ro Review
James MitchellMSc Biochemistry Methodology score
68
Provisional score last reviewed 2026-05-28. Scores are reviewed quarterly and are not influenced by commission rates.
Independent testing
14/30
COA accessibility
6/15
Manufacturing transparency
12/15
Support responsiveness
9/10
Shipping transparency
9/10
Years and community signal
9/10
Pricing transparency
9/10
Verification status
Ro is listed as a regulated telehealth pathway for prescription-product education. It is not scored as a research peptide vendor. Ro’s public weight-loss page lists access to FDA-approved GLP-1 options such as Wegovy and Zepbound when clinically appropriate.
What we review
- Clear clinical pathway disclosure
- Prescription and pharmacy framing
- Pricing transparency
- Support and customer-service signals
- Affiliate disclosure
Affiliate disclosure
PeptideUnicorn does not currently show an active affiliate relationship for this profile. Editorial coverage stays separate from any future commission terms.
Summary
This profile helps the quiz and directory distinguish regulated clinical pathways from research-vendor education.
State of Peptides 2026
Get the free report and weekly peptide updates.
New profiles, regulatory changes, practical guides, and vendor review notes. Education only - not medical advice.
Get the PeptideUnicorn update
New profiles, regulatory changes, practical guides, and vendor review notes delivered to your inbox.
Get our free State of Peptides 2026 report when you subscribe.